Sensorimotor gating of schizophrenia patients is influenced by 5-HT2A receptor polymorphisms

Biological Psychiatry
Boris B QuednowMichael Wagner

Abstract

Schizophrenia patients exhibit impairment in prepulse inhibition (PPI) of the acoustic startle response (ASR), suggesting a sensorimotor gating deficit. The serotonin-2A receptor (5-HT(2A)R) has been implicated in both the pathogenesis of schizophrenia and the PPI deficits of schizophrenia patients. Moreover, both schizophrenia and PPI are thought to be inheritable. We investigated the impact of three 5-HT(2A)R polymorphisms (A-1438G, T102C, H452Y) on PPI in schizophrenia patients. We analyzed the 5-HT(2A)R A-1438G, T102C, and H452Y polymorphisms and assessed startle reactivity, habituation, and PPI of ASR in 68 Caucasian schizophrenia inpatients. Patients were also examined with the Positive and Negative Syndrome Scale. The 5-HT(2A)R A-1438G and T102C polymorphisms were in complete linkage disequilibrium. Patients carrying the T102C TT and the A-1438G AA allele show significantly higher PPI levels and a faster early habituation compared with all other variants. 5-HT(2A)R A-1438G and T102C genotype explained approximately 11% of the PPI and early habituation variance. In contrast, the 5-HT(2A)R H452Y polymorphism did not affect startle parameters. Our findings suggest that PPI and habituation are modulated by 5-HT(2A)R A-1438G ...Continue Reading

References

May 1, 1988·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M A Geyer, G S Tapson
Feb 22, 2000·Biological Psychiatry·M Tsuang
Dec 12, 2002·Molecular Psychiatry·M A GeyerR Paylor
Jul 11, 2003·Biological Psychology·Katja LudewigFranz X Vollenweider
Aug 23, 2003·Behavioral Neuroscience·James F WillottLeona Gagnon
Dec 4, 2003·Neuroscience Letters·Andrey P AnokhinSuzanne Wood
Jan 27, 2004·Schizophrenia Research·Hamid Mostafavi AbdolmalekyMing T Tsuang
Sep 15, 2004·Biological Psychiatry·Michael J ParsonsAndrew J Makoff
Jan 24, 2007·European Psychiatry : the Journal of the Association of European Psychiatrists·V E GolimbetT V Lezheiko
Feb 15, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Franz X VollenweiderBoris B Quednow
Jul 17, 2007·Biological Psychiatry·L Elliot HongGunvant K Thaker
Nov 27, 2007·Behavioural Brain Research·Christian MontagMartin Reuter

❮ Previous
Next ❯

Citations

Jan 10, 2009·Der Nervenarzt·R MössnerD Rujescu
Dec 5, 2008·European Archives of Psychiatry and Clinical Neuroscience·Wolfgang MaierRené Hurlemann
Sep 21, 2011·European Archives of Psychiatry and Clinical Neuroscience·Leonhard LennertzRainald Mössner
Oct 16, 2012·Psychiatry Research·Hui-Chun TsuangHsien-Yuan Lane
Apr 16, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nadine PetrovskyVeena Kumari
Oct 1, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Boris B QuednowFranz X Vollenweider
Apr 8, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Panos RoussosPanos Bitsios
May 20, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ryota HashimotoMasatoshi Takeda
Jan 18, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Terrell HollowayJavier González-Maeso
Nov 15, 2011·The Behavioral and Brain Sciences·Christian P Müller, Gunter Schumann
Jul 12, 2011·Expert Opinion on Investigational Drugs·Bjørn H EbdrupBirte Glenthøj
Jun 5, 2012·Journal of Psychiatric Research·Anna SchuhmacherRainald Mössner
Nov 9, 2011·Neuroscience Research·Hidetoshi TakahashiMasatoshi Takeda
Aug 23, 2011·Medical Hypotheses·Lei ZhangRobert Ursano
Mar 17, 2016·Cognitive Neuropsychiatry·Jing ShiXingguang Luo
Dec 10, 2013·Clinical Physiology and Functional Imaging·Huirong GuoJianhua Zhang
Jun 3, 2008·Biological Psychiatry·Boris B QuednowMichael Wagner
Dec 1, 2011·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Hidetoshi TakahashiMasatoshi Takeda
Aug 15, 2013·The International Journal of Neuropsychopharmacology·Adam L Halberstadt, Mark A Geyer
Sep 7, 2016·Nordic Journal of Psychiatry·Li SunYi-Ping Liu
May 8, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Philipp A CsomorFranz X Vollenweider
Jun 27, 2020·Frontiers in Psychiatry·Michelle A LandNoelle C Anastasio
Aug 21, 2015·Behavioural Pharmacology·Lena Wischhof, Michael Koch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here